{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T12:53:04Z","timestamp":1788267184155,"version":"build-2803163510"},"reference-count":95,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,2,5]],"date-time":"2027-02-05T00:00:00Z","timestamp":1801785600000},"content-version":"am","delay-in-days":341,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"NIH National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["K23GM159013"],"award-info":[{"award-number":["K23GM159013"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Chest Medicine"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ccm.2025.11.001","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T12:29:51Z","timestamp":1766406591000},"page":"57-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pediatric Sepsis"],"prefix":"10.1016","volume":"47","author":[{"given":"Steven D.","family":"Ham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie C.","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B.","family":"Lindell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccm.2025.11.001_bib1","unstructured":"Organization WH. Global report on the epidemiology and burden of sepsis: current evidence, identifying gaps and future directions. 2020."},{"issue":"3","key":"10.1016\/j.ccm.2025.11.001_bib2","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1164\/rccm.201504-0781OC","article-title":"Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations","volume":"193","author":"Fleischmann","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"issue":"10219","key":"10.1016\/j.ccm.2025.11.001_bib3","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the global burden of disease study","volume":"395","author":"Rudd","year":"2020","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.ccm.2025.11.001_bib4","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1001\/jama.2024.0196","article-title":"Development and validation of the phoenix criteria for pediatric sepsis and septic shock","volume":"331","author":"Sanchez-Pinto","year":"2024","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.ccm.2025.11.001_bib5","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1001\/jama.2024.0179","article-title":"International consensus criteria for pediatric sepsis and septic shock","volume":"331","author":"Schlapbach","year":"2024","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ccm.2025.11.001_bib6","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/01.PCC.0000149131.72248.E6","article-title":"International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics","volume":"6","author":"Goldstein","year":"2005","journal-title":"Pediatr Crit Care Med"},{"issue":"4","key":"10.1016\/j.ccm.2025.11.001_bib7","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/01.PCC.0000164344.07588.83","article-title":"Values for systolic blood pressure","volume":"6","author":"Gebara","year":"2005","journal-title":"Pediatr Crit Care Med"},{"issue":"6","key":"10.1016\/j.ccm.2025.11.001_bib8","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1378\/chest.101.6.1644","article-title":"Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP\/SCCM Consensus Conference Committee. American College of Chest Physicians\/Society of Critical Care Medicine","volume":"101","author":"Bone","year":"1992","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.ccm.2025.11.001_bib9","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1097\/01.CCM.0000050454.01978.3B","article-title":"2001 SCCM\/ESICM\/ACCP\/ATS\/SIS international sepsis definitions conference","volume":"31","author":"Levy","year":"2003","journal-title":"Crit Care Med"},{"issue":"4","key":"10.1016\/j.ccm.2025.11.001_bib10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.molmed.2014.01.007","article-title":"Why have clinical trials in sepsis failed?","volume":"20","author":"Marshall","year":"2014","journal-title":"Trends Mol Med"},{"issue":"7","key":"10.1016\/j.ccm.2025.11.001_bib11","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1097\/00003246-199707000-00010","article-title":"Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group","volume":"25","author":"Opal","year":"1997","journal-title":"Crit Care Med"},{"issue":"3","key":"10.1016\/j.ccm.2025.11.001_bib12","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/00003246-200103000-00006","article-title":"Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: a randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients","volume":"29","author":"Abraham","year":"2001","journal-title":"Crit Care Med"},{"issue":"9107","key":"10.1016\/j.ccm.2025.11.001_bib13","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0140-6736(05)60602-2","article-title":"Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II study group","volume":"351","author":"Abraham","year":"1998","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.ccm.2025.11.001_bib14","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1056\/NEJMoa1202290","article-title":"Drotrecogin alfa (activated) in adults with septic shock","volume":"366","author":"Ranieri","year":"2012","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ccm.2025.11.001_bib15","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/01.PCC.0000217470.68764.36","article-title":"ENHANCE: results of a global open-label trial of drotrecogin alfa (activated) in children with severe sepsis","volume":"7","author":"Goldstein","year":"2006","journal-title":"Pediatr Crit Care Med"},{"issue":"7","key":"10.1016\/j.ccm.2025.11.001_bib16","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1097\/00003246-199607000-00010","article-title":"Sir Isaac Newton, sepsis, SIRS, and CARS","volume":"24","author":"Bone","year":"1996","journal-title":"Crit Care Med"},{"issue":"12","key":"10.1016\/j.ccm.2025.11.001_bib17","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nri3552","article-title":"Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy","volume":"13","author":"Hotchkiss","year":"2013","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.ccm.2025.11.001_bib18","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41420-023-01766-7","article-title":"Immune dysregulation in sepsis: experiences, lessons and perspectives","volume":"9","author":"Cao","year":"2023","journal-title":"Cell Death Discov"},{"issue":"8","key":"10.1016\/j.ccm.2025.11.001_bib19","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ccm.2025.11.001_bib20","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00134-017-5021-8","article-title":"Prognostic accuracy of age-adapted SOFA, SIRS, PELOD-2, and qSOFA for in-hospital mortality among children with suspected infection admitted to the intensive care unit","volume":"44","author":"Schlapbach","year":"2018","journal-title":"Intensive Care Med"},{"issue":"5","key":"10.1016\/j.ccm.2025.11.001_bib21","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jped.2019.07.007","article-title":"Day-1 PELOD-2 and day-1 \u201cquick\u201d PELOD-2 scores in children with sepsis in the PICU","volume":"96","author":"Zhong","year":"2020","journal-title":"J Pediatr"},{"issue":"6","key":"10.1016\/j.ccm.2025.11.001_bib22","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/PEC.0000000000002938","article-title":"Sepsis prognostic scores accuracy in predicting adverse outcomes in children with sepsis admitted to the pediatric intensive care unit from the emergency department: a 10-Year single-center experience","volume":"39","author":"Marchetto","year":"2023","journal-title":"Pediatr Emerg Care"},{"issue":"6","key":"10.1016\/j.ccm.2025.11.001_bib23","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2021-052565","article-title":"The current and future state of pediatric sepsis definitions: an international survey","volume":"149","author":"Morin","year":"2022","journal-title":"Pediatrics"},{"issue":"8","key":"10.1016\/j.ccm.2025.11.001_bib24","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1001\/jama.2016.0288","article-title":"Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Seymour","year":"2016","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.ccm.2025.11.001_bib25","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/PCC.0000000000003292","article-title":"Derivation, validation, and clinical relevance of a pediatric sepsis phenotype with persistent hypoxemia, encephalopathy, and shock","volume":"24","author":"Sanchez-Pinto","year":"2023","journal-title":"Pediatr Crit Care Med"},{"issue":"5","key":"10.1016\/j.ccm.2025.11.001_bib26","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1097\/CCM.0b013e318246b546","article-title":"Genetics and genomics in pediatric septic shock","volume":"40","author":"Wong","year":"2012","journal-title":"Crit Care Med"},{"issue":"3","key":"10.1016\/j.ccm.2025.11.001_bib27","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1164\/rccm.201410-1864OC","article-title":"Developing a clinically feasible personalized medicine approach to pediatric septic shock","volume":"191","author":"Wong","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.ccm.2025.11.001_bib28","doi-asserted-by":"crossref","first-page":"e242","DOI":"10.1097\/CCM.0000000000002932","article-title":"Endotype transitions during the acute phase of pediatric septic shock reflect changing risk and treatment response","volume":"46","author":"Wong","year":"2018","journal-title":"Crit Care Med"},{"issue":"5","key":"10.1016\/j.ccm.2025.11.001_bib29","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1542\/peds.2009-3301","article-title":"The host response to sepsis and developmental impact","volume":"125","author":"Wynn","year":"2010","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.ccm.2025.11.001_bib30","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1056\/NEJMp1707170","article-title":"Recognizing sepsis as a global health priority - a WHO resolution","volume":"377","author":"Reinhart","year":"2017","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.ccm.2025.11.001_bib31","doi-asserted-by":"crossref","first-page":"e625","DOI":"10.1097\/PCC.0000000000001340","article-title":"Sepsis in children: global implications of the World Health Assembly Resolution on sepsis","volume":"18","author":"Kissoon","year":"2017","journal-title":"Pediatr Crit Care Med"},{"issue":"4","key":"10.1016\/j.ccm.2025.11.001_bib32","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.ccm.2008.06.011","article-title":"Reducing mortality in severe sepsis: the Surviving Sepsis Campaign","volume":"29","author":"Townsend","year":"2008","journal-title":"Clin Chest Med"},{"issue":"2","key":"10.1016\/j.ccm.2025.11.001_bib33","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1097\/PCC.0000000000002198","article-title":"Surviving sepsis Campaign International Guidelines for the management of septic shock and sepsis-associated organ dysfunction in children","volume":"21","author":"Weiss","year":"2020","journal-title":"Pediatr Crit Care Med"},{"issue":"4","key":"10.1016\/j.ccm.2025.11.001_bib34","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1001\/jamapediatrics.2018.4839","article-title":"Global case-fatality rates in pediatric severe sepsis and septic shock: a systematic review and meta-analysis","volume":"173","author":"Tan","year":"2019","journal-title":"JAMA Pediatr"},{"issue":"2","key":"10.1016\/j.ccm.2025.11.001_bib35","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/CCM.0b013e31827e83af","article-title":"Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012","volume":"41","author":"Dellinger","year":"2013","journal-title":"Crit Care Med"},{"issue":"3","key":"10.1016\/j.ccm.2025.11.001_bib36","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.1412","article-title":"External validation of the phoenix sepsis score in children with suspected community-acquired sepsis","volume":"8","author":"Long","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.ccm.2025.11.001_bib37","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/CCM.0000000000004123","article-title":"Trajectory of mortality and health-related quality of life morbidity following community-acquired pediatric septic shock","volume":"48","author":"Zimmerman","year":"2020","journal-title":"Crit Care Med"},{"issue":"3","key":"10.1016\/j.ccm.2025.11.001_bib38","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.1816","article-title":"Bringing pediatric chronic critical illness into acute focus","volume":"7","author":"Graham","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ccm.2025.11.001_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.686206","article-title":"Chronic illness in pediatric critical care","volume":"9","author":"Murphy Salem","year":"2021","journal-title":"Front Pediatr"},{"issue":"3","key":"10.1016\/j.ccm.2025.11.001_bib40","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1542\/peds.2010-0910","article-title":"Children with medical complexity: an emerging population for clinical and research initiatives","volume":"127","author":"Cohen","year":"2011","journal-title":"Pediatrics"},{"issue":"7","key":"10.1016\/j.ccm.2025.11.001_bib41","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/PCC.0b013e3182917fad","article-title":"Trends in the epidemiology of pediatric severe sepsis","volume":"14","author":"Hartman","year":"2013","journal-title":"Pediatr Crit Care Med"},{"issue":"10","key":"10.1016\/j.ccm.2025.11.001_bib42","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1164\/rccm.201412-2323OC","article-title":"Global epidemiology of pediatric severe sepsis: the sepsis prevalence, outcomes, and therapies study","volume":"191","author":"Weiss","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.ccm.2025.11.001_bib43","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1097\/CCM.0000000000004329","article-title":"Risk of mortality in immunocompromised children with severe sepsis and septic shock","volume":"48","author":"Lindell","year":"2020","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ccm.2025.11.001_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.940930","article-title":"The neonatal innate immune response to sepsis: checkpoint proteins as novel mediators of this response and as possible therapeutic\/diagnostic levers","volume":"13","author":"Hensler","year":"2022","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.ccm.2025.11.001_bib45","doi-asserted-by":"crossref","first-page":"7150","DOI":"10.4049\/jimmunol.0901481","article-title":"Neonatal innate TLR-mediated responses are distinct from those of adults","volume":"183","author":"Kollmann","year":"2009","journal-title":"J Immunol"},{"issue":"11\u201312","key":"10.1016\/j.ccm.2025.11.001_bib46","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.2119\/molmed.2011.00169","article-title":"The influence of developmental age on the early transcriptomic response of children with septic shock","volume":"17","author":"Wynn","year":"2011","journal-title":"Mol Med"},{"key":"10.1016\/j.ccm.2025.11.001_bib47","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3389\/fped.2017.00014","article-title":"Immunological defects in neonatal sepsis and potential therapeutic approaches","volume":"5","author":"Raymond","year":"2017","journal-title":"Front Pediatr"},{"issue":"9","key":"10.1016\/j.ccm.2025.11.001_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184159","article-title":"Unique transcriptomic response to sepsis is observed among patients of different age groups","volume":"12","author":"Raymond","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ccm.2025.11.001_bib49","article-title":"Understanding early-life adaptive immunity to guide interventions for pediatric health","volume":"11","author":"Semmes","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.ccm.2025.11.001_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109728","article-title":"Age-dependent transcriptomic profiles of leukocytes in pediatric population","volume":"255","author":"Koutsogiannaki","year":"2023","journal-title":"Clin Immunol"},{"key":"10.1016\/j.ccm.2025.11.001_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1527142","article-title":"Age influences the circulating immune profile in pediatric sepsis","volume":"16","author":"Fisler","year":"2025","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.ccm.2025.11.001_bib52","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/SHK.0000000000001943","article-title":"Impaired lymphocyte responses in pediatric sepsis vary by pathogen type and are associated with features of immunometabolic dysregulation","volume":"57","author":"Lindell","year":"2022","journal-title":"Shock"},{"key":"10.1016\/j.ccm.2025.11.001_bib53","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/1875041901104010004","article-title":"Pediatric sepsis - part I: \u201cchildren are not small adults!\u201d","volume":"4","author":"Wheeler","year":"2011","journal-title":"Open Inflamm J"},{"issue":"9","key":"10.1016\/j.ccm.2025.11.001_bib54","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1097\/PCC.0000000000000254","article-title":"Pediatric severe sepsis: current trends and outcomes from the pediatric health information systems database","volume":"15","author":"Ruth","year":"2014","journal-title":"Pediatr Crit Care Med"},{"issue":"9","key":"10.1016\/j.ccm.2025.11.001_bib55","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1097\/PCC.0000000000000225","article-title":"Pediatric severe sepsis in U.S. children's hospitals","volume":"15","author":"Balamuth","year":"2014","journal-title":"Pediatr Crit Care Med"},{"issue":"5","key":"10.1016\/j.ccm.2025.11.001_bib56","first-page":"1089","article-title":"Immunoparalysis in pediatric critical care","volume":"64","author":"Hall","year":"2017","journal-title":"Pediatr Clin"},{"issue":"23","key":"10.1016\/j.ccm.2025.11.001_bib57","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine storm","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.ccm.2025.11.001_bib58","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1182\/blood.2020009499","article-title":"T-cell activation profiles distinguish hemophagocytic lymphohistiocytosis and early sepsis","volume":"137","author":"Chaturvedi","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.ccm.2025.11.001_bib59","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/978-3-031-59815-9_30","article-title":"Cytokine storm and sepsis-induced multiple organ dysfunction syndrome","volume":"1448","author":"Carcillo","year":"2024","journal-title":"Adv Exp Med Biol"},{"issue":"10","key":"10.1016\/j.ccm.2025.11.001_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens10101239","article-title":"Immune function in critically ill septic children","volume":"10","author":"Bline","year":"2021","journal-title":"Pathogens"},{"issue":"1","key":"10.1016\/j.ccm.2025.11.001_bib61","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1055\/s-0038-1676607","article-title":"Immune modulation in pediatric sepsis","volume":"8","author":"Hall","year":"2019","journal-title":"J Pediatr Intensive Care"},{"issue":"4","key":"10.1016\/j.ccm.2025.11.001_bib62","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.coi.2013.05.006","article-title":"Monitoring the immune response in sepsis: a rational approach to administration of immunoadjuvant therapies","volume":"25","author":"Venet","year":"2013","journal-title":"Curr Opin Immunol"},{"issue":"6","key":"10.1016\/j.ccm.2025.11.001_bib63","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nm0697-678","article-title":"Monocyte deactivation in septic patients: restoration by IFN-gamma treatment","volume":"3","author":"Docke","year":"1997","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.ccm.2025.11.001_bib64","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1164\/rccm.201710-2006OC","article-title":"Early immune function and duration of organ dysfunction in critically III children with sepsis","volume":"198","author":"Muszynski","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.ccm.2025.11.001_bib65","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/SHK.0000000000000217","article-title":"Innate immune function predicts the development of nosocomial infection in critically injured children","volume":"42","author":"Muszynski","year":"2014","journal-title":"Shock"},{"issue":"3","key":"10.1016\/j.ccm.2025.11.001_bib66","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00134-010-2088-x","article-title":"Immunoparalysis and nosocomial infection in children with multiple organ dysfunction syndrome","volume":"37","author":"Hall","year":"2011","journal-title":"Intensive Care Med"},{"issue":"9","key":"10.1016\/j.ccm.2025.11.001_bib67","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1097\/PCC.0000000000001222","article-title":"The Epidemiology of Hospital Death Following Pediatric Severe Sepsis: when, Why, and How Children With Sepsis Die","volume":"18","author":"Weiss","year":"2017","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.ccm.2025.11.001_bib68","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1741-7015-7-34","article-title":"Identification of pediatric septic shock subclasses based on genome-wide expression profiling","volume":"7","author":"Wong","year":"2009","journal-title":"BMC Med"},{"issue":"518","key":"10.1016\/j.ccm.2025.11.001_bib69","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax9000","article-title":"Prospective clinical testing and experimental validation of the pediatric sepsis biomarker risk model","volume":"11","author":"Wong","year":"2019","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.ccm.2025.11.001_bib70","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s13054-024-05020-z","article-title":"Identification and transcriptomic assessment of latent profile pediatric septic shock phenotypes","volume":"28","author":"Atreya","year":"2024","journal-title":"Crit Care"},{"issue":"5","key":"10.1016\/j.ccm.2025.11.001_bib71","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/SHK.0000000000001906","article-title":"Temperature trajectory sub-phenotypes and the immuno-inflammatory response in pediatric sepsis","volume":"57","author":"Yehya","year":"2022","journal-title":"Shock"},{"issue":"12","key":"10.1016\/j.ccm.2025.11.001_bib72","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1097\/PCC.0000000000002105","article-title":"A multicenter network assessment of three inflammation phenotypes in pediatric sepsis-induced multiple organ failure","volume":"20","author":"Carcillo","year":"2019","journal-title":"Pediatr Crit Care Med"},{"issue":"2","key":"10.1016\/j.ccm.2025.11.001_bib73","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"10.1016\/j.ccm.2025.11.001_bib74","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1186\/s13054-023-04628-x","article-title":"Hyperferritinemic sepsis, macrophage activation syndrome, and mortality in a pediatric research network: a causal inference analysis","volume":"27","author":"Fan","year":"2023","journal-title":"Crit Care"},{"issue":"4","key":"10.1016\/j.ccm.2025.11.001_bib75","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1378\/chest.11-0619","article-title":"Hemophagocytic lymphohistiocytosis: a potentially underrecognized association with systemic inflammatory response syndrome, severe sepsis, and septic shock in adults","volume":"140","author":"Raschke","year":"2011","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.ccm.2025.11.001_bib76","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/ACI.0000000000000405","article-title":"Comparing hemophagocytic lymphohistiocytosis in pediatric and adult patients","volume":"17","author":"Wysocki","year":"2017","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.ccm.2025.11.001_bib77","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00130478-200107000-00001","article-title":"Microvascular thrombosis in pediatric multiple organ failure: is it a therapeutic target?","volume":"2","author":"Nguyen","year":"2001","journal-title":"Pediatr Crit Care Med"},{"issue":"6","key":"10.1016\/j.ccm.2025.11.001_bib78","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/cc5064","article-title":"Bench-to-bedside review: thrombocytopenia-associated multiple organ failure--a newly appreciated syndrome in the critically ill","volume":"10","author":"Nguyen","year":"2006","journal-title":"Crit Care"},{"issue":"10","key":"10.1016\/j.ccm.2025.11.001_bib79","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1097\/CCM.0b013e318186aa49","article-title":"Intensive plasma exchange increases a disintegrin and metalloprotease with thrombospondin motifs-13 activity and reverses organ dysfunction in children with thrombocytopenia-associated multiple organ failure","volume":"36","author":"Nguyen","year":"2008","journal-title":"Crit Care Med"},{"issue":"3","key":"10.1016\/j.ccm.2025.11.001_bib80","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.1097\/CCM.0000000000003559","article-title":"Therapeutic plasma exchange in children with Thrombocytopenia-Associated multiple organ failure: the Thrombocytopenia-Associated multiple organ failure network prospective experience","volume":"47","author":"Fortenberry","year":"2019","journal-title":"Crit Care Med"},{"issue":"4","key":"10.1016\/j.ccm.2025.11.001_bib81","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S2213-2600(24)00070-5","article-title":"Charting a course for precision therapy trials in sepsis","volume":"12","author":"Lindell","year":"2024","journal-title":"Lancet Respir Med"},{"issue":"11","key":"10.1016\/j.ccm.2025.11.001_bib82","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S2213-2600(23)00237-0","article-title":"Identifying molecular phenotypes in sepsis: an analysis of two prospective observational cohorts and secondary analysis of two randomised controlled trials","volume":"11","author":"Sinha","year":"2023","journal-title":"Lancet Respir Med"},{"issue":"5","key":"10.1016\/j.ccm.2025.11.001_bib83","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1186\/s13054-014-0503-3","article-title":"Sepsis-associated hyperlactatemia","volume":"18","author":"Garcia-Alvarez","year":"2014","journal-title":"Crit Care"},{"issue":"2","key":"10.1016\/j.ccm.2025.11.001_bib84","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1651-2227.1997.tb08870.x","article-title":"Procalcitonin and C-reactive protein levels in neonatal infections","volume":"86","author":"Monneret","year":"1997","journal-title":"Acta Paediatr"},{"issue":"1","key":"10.1016\/j.ccm.2025.11.001_bib85","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/s12887-022-03285-3","article-title":"Biomarker combinations in predicting sepsis in hospitalized children with fever","volume":"22","author":"Rautiainen","year":"2022","journal-title":"BMC Pediatr"},{"issue":"6","key":"10.1016\/j.ccm.2025.11.001_bib86","doi-asserted-by":"crossref","DOI":"10.1186\/cc13157","article-title":"Procalcitonin-guided therapy in intensive care unit patients with severe sepsis and septic shock--a systematic review and meta-analysis","volume":"17","author":"Prkno","year":"2013","journal-title":"Crit Care"},{"issue":"5","key":"10.1016\/j.ccm.2025.11.001_bib87","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S1473-3099(12)70323-7","article-title":"Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis","volume":"13","author":"Wacker","year":"2013","journal-title":"Lancet Infect Dis"},{"issue":"10097","key":"10.1016\/j.ccm.2025.11.001_bib88","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0140-6736(17)31444-7","article-title":"Procalcitonin-guided decision making for duration of antibiotic therapy in neonates with suspected early-onset sepsis: a multicentre, randomised controlled trial (NeoPIns)","volume":"390","author":"Stocker","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ccm.2025.11.001_bib89","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1586\/eri.10.154","article-title":"Biomarkers for pediatric sepsis and septic shock","volume":"9","author":"Standage","year":"2011","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"2","key":"10.1016\/j.ccm.2025.11.001_bib90","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jaci.2024.08.030","article-title":"Serum cytokine panels in pediatric clinical practice","volume":"155","author":"Gallo","year":"2025","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.ccm.2025.11.001_bib91","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12950-024-00379-w","article-title":"Pediatric sepsis inflammatory blood biomarkers that correlate with clinical variables and severity of illness scores","volume":"21","author":"Leonard","year":"2024","journal-title":"J Inflamm"},{"issue":"7","key":"10.1016\/j.ccm.2025.11.001_bib92","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24505","article-title":"Combination of C-reactive protein, procalcitonin, IL-6, IL-8, and IL-10 for early diagnosis of hyperinflammatory state and organ dysfunction in pediatric sepsis","volume":"36","author":"Zeng","year":"2022","journal-title":"J Clin Lab Anal"},{"issue":"11","key":"10.1016\/j.ccm.2025.11.001_bib93","article-title":"Toward personalized immunotherapy in sepsis: the PROVIDE randomized clinical trial","volume":"3","author":"Leventogiannis","year":"2022","journal-title":"Cell Rep Med"},{"issue":"12","key":"10.1016\/j.ccm.2025.11.001_bib94","doi-asserted-by":"crossref","first-page":"e635","DOI":"10.1097\/PCC.0000000000003332","article-title":"The design of nested adaptive clinical trials of multiple organ dysfunction syndrome children in a single study","volume":"24","author":"VanBuren","year":"2023","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.ccm.2025.11.001_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105414","article-title":"Interferon-gamma driven elevation of CXCL9: a new sepsis endotype independently associated with mortality","volume":"109","author":"Giamarellos-Bourboulis","year":"2024","journal-title":"EBioMedicine"}],"container-title":["Clinics in Chest Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523125000954?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523125000954?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T14:20:27Z","timestamp":1773930027000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272523125000954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":95,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0272523125000954"],"URL":"https:\/\/doi.org\/10.1016\/j.ccm.2025.11.001","relation":{},"ISSN":["0272-5231"],"issn-type":[{"value":"0272-5231","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pediatric Sepsis","name":"articletitle","label":"Article Title"},{"value":"Clinics in Chest Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccm.2025.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}